Abstract：
Molecular profiling and testing for oncogenic driver mutations is an essential component in the diagnosis of patients with advanced non-small cell lung cancer (NSCLC). Results of these tests guide personalized targeted therapy in patients with NSCLC harboring an oncogenic driver. Advanced practice nurses are at the center of coordinating care for patients with NSCLC from the time of diagnosis and have a role in assuring appropriate testing is ordered and therapy is selected based on testing results.
摘要：
癌基因驱动突变的分子分析和检测是晚期非小细胞肺癌（NSCLC）患者诊断的重要组成部分。这些测试的结果指导具有致癌驱动因素的NSCLC患者的个性化靶向治疗。从诊断开始，高级执业护士就处于协调NSCLC患者护理的中心，并在确保订购适当的测试并根据测试结果选择治疗方面发挥作用。
